Fold Rise in Antibody Titers by Measured by Glycoprotein-Based Enzyme-Linked Immunosorbent Assay Is an Excellent Correlate of Protection for a Herpes Zoster Vaccine, Demonstrated via the Vaccine Efficacy Curve

Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials

(2013) Ying Huang et al.   BIOMETRICS

Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacy

(2013) E. E. Gabriel et al.   BIOSTATISTICS

Varicella-Zoster Virus–Specific Antibody Responses in 50–59-Year-Old Recipients of Zoster Vaccine

(2013) Myron J. Levin et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years

(2012) K. E. Schmader et al.   CLINICAL INFECTIOUS DISEASES

Nomenclature for Immune Correlates of Protection After Vaccination

(2012) S. A. Plotkin et al.   CLINICAL INFECTIOUS DISEASES

Comparing Biomarkers as Principal Surrogate Endpoints

(2011) Ying Huang et al.   BIOMETRICS

Commentary on "Principal Stratification -- a Goal or a Tool?" by Judea Pearl

(2011) Peter B. Gilbert et al.  

Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials

(2010) Julian Wolfson et al.   BIOMETRICS

The impact of herpes zoster and post-herpetic neuralgia on quality-of-life

(2010) Robert W Johnson et al.   BMC Medicine

Correlates of Protection Induced by Vaccination

(2010) S. A. Plotkin   Clinical and Vaccine Immunology

Varicella‐Zoster Virus–Specific Immune Responses to Herpes Zoster in Elderly Participants in a Trial of a Clinically Effective Zoster Vaccine

(2009) Adriana Weinberg et al.   JOURNAL OF INFECTIOUS DISEASES

Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model

(2008) Li Qin et al.   Annals of Applied Statistics

Evaluating Candidate Principal Surrogate Endpoints

(2008) Peter B. Gilbert et al.   BIOMETRICS

Vaccines: Correlates of Vaccine‐Induced Immunity

(2008) Stanley A. Plotkin   CLINICAL INFECTIOUS DISEASES

Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine

(2008) M. J. Levin et al.   JOURNAL OF INFECTIOUS DISEASES

Prediction of pertussis vaccine efficacy using a correlates of protection model

(2008) Robert C. Kohberger et al.   VACCINE

Evaluating a surrogate endpoint at three levels, with application to vaccine development

(2007) Peter B. Gilbert et al.   STATISTICS IN MEDICINE